Key facts
- This page summarizes Neil Herskowitz's Form 4 filing for Checkpoint Therapeutics, Inc. (CKPT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jun 2022, 21:54.
Neil Herskowitz - 16 Jun 2022 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)
- Reporting relationship
- Director
- Issuer ticker
- CKPT
- Reported as of
- 16 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Jun 2022, 21:54:37 UTC
- Prior SEC filing
- 04 Apr 2022
- Next SEC filing
- 25 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ James F. Oliviero, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Neil Herskowitz filed Form 4 for Checkpoint Therapeutics, Inc. (CKPT) on 24 Jun 2022.
Change
- Previous filing in this sequence was filed on 04 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CKPT
transaction
COMMON STOCK
Award
- Transaction value
- $0
- Shares
- +47,619
- Change %
- +37%
- Price
- $0.000000
- Shares after
- 176,401
- Date
- 16 Jun 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The 47,619 shares of restricted Common Stock will vest on June 16, 2025, subject to Mr. Herskowitz's continued service on the board on such date.
Footnote F2
Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board.